Glassman Wealth Services Tg Therapeutics, Inc. Transaction History

Glassman Wealth Services

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$3.74 - $10.66 $287 - $820	-77 Closed	0 $0
Q1 2022 Apr 14, 2022	BUY	$7.81 - $20.45 $601 - $1,574	77 New	77 $1,000
Q4 2021 Feb 14, 2022	SELL	$15.2 - $35.51 $988 - $2,308	-65 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$21.78 - $40.45 $1,415 - $2,629	65 New	65 $2,000

338

88.3M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.